Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the tr… Read more
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) - Net Assets
Latest net assets as of June 2025: €1.30 Trillion EUR
Based on the latest financial reports, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) has net assets worth €1.30 Trillion EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.60 Trillion) and total liabilities (€298.87 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.30 Trillion |
| % of Total Assets | 81.33% |
| Annual Growth Rate | 8.14% |
| 5-Year Change | 60.19% |
| 10-Year Change | 110.85% |
| Growth Volatility | 5.38 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Net Assets Trend (2013–2024)
This chart illustrates how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2024)
The table below shows the annual net assets of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.30 Trillion | +14.12% |
| 2023-12-31 | €1.14 Trillion | +7.75% |
| 2022-12-31 | €1.06 Trillion | +14.88% |
| 2021-12-31 | €923.02 Billion | +13.40% |
| 2020-12-31 | €813.94 Billion | +12.29% |
| 2019-12-31 | €724.87 Billion | +5.71% |
| 2018-12-31 | €685.75 Billion | +3.27% |
| 2017-12-31 | €664.02 Billion | -2.62% |
| 2016-12-31 | €681.87 Billion | +10.27% |
| 2015-12-31 | €618.39 Billion | +10.09% |
| 2014-12-31 | €561.73 Billion | +1.91% |
| 2013-12-31 | €551.20 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 143.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.22 Trillion | 93.73% |
| Other Components | €81.53 Billion | 6.27% |
| Total Equity | €1.30 Trillion | 100.00% |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Competitors by Market Cap
The table below lists competitors of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dpm Metals Inc.
AU:DPM
|
$4.70 Billion |
|
Clearway Energy Inc
NYSE:CWEN-A
|
$4.71 Billion |
|
Endeavour Mining Corp
OTCQX:EDVMF
|
$4.71 Billion |
|
SentinelOne Inc
NYSE:S
|
$4.71 Billion |
|
Cleveland-Cliffs Inc
NYSE:CLF
|
$4.69 Billion |
|
Wintime Energy Co Ltd
SHG:600157
|
$4.69 Billion |
|
Adecco Group AG
PINK:AHEXF
|
$4.69 Billion |
|
China Shipbuilding Industry Group Power Co Ltd
SHG:600482
|
$4.69 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,130,814,000,000 to 1,300,462,000,000, a change of 169,648,000,000 (15.0%).
- Net income of 239,244,000,000 contributed positively to equity growth.
- Dividend payments of 79,079,000,000 reduced retained earnings.
- Share repurchases of 6,937,000,000 reduced equity.
- Other factors increased equity by 16,420,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €239.24 Billion | +18.4% |
| Dividends Paid | €79.08 Billion | -6.08% |
| Share Repurchases | €6.94 Billion | -0.53% |
| Other Changes | €16.42 Billion | +1.26% |
| Total Change | €- | 15.00% |
Book Value vs Market Value Analysis
This analysis compares Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €3538.90 | €30.64 | x |
| 2018-12-31 | €3649.55 | €30.64 | x |
| 2019-12-31 | €3866.34 | €30.64 | x |
| 2020-12-31 | €4344.46 | €30.64 | x |
| 2021-12-31 | €4922.99 | €30.64 | x |
| 2022-12-31 | €5646.29 | €30.64 | x |
| 2023-12-31 | €6186.99 | €30.64 | x |
| 2024-12-31 | €7130.46 | €30.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.40%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 27.90%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.23x
- Recent ROE (18.40%) is above the historical average (9.95%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 7.80% | 12.15% | 0.49x | 1.30x | €-12.07 Billion |
| 2014 | 4.47% | 7.05% | 0.49x | 1.29x | €-30.91 Billion |
| 2015 | 8.75% | 14.75% | 0.49x | 1.21x | €-7.66 Billion |
| 2016 | 9.76% | 16.99% | 0.48x | 1.20x | €-1.60 Billion |
| 2017 | 1.35% | 2.00% | 0.58x | 1.15x | €-57.05 Billion |
| 2018 | 5.20% | 7.93% | 0.56x | 1.17x | €-32.67 Billion |
| 2019 | 6.56% | 9.28% | 0.59x | 1.20x | €-24.66 Billion |
| 2020 | 12.97% | 18.47% | 0.60x | 1.18x | €23.99 Billion |
| 2021 | 15.26% | 22.14% | 0.55x | 1.25x | €48.14 Billion |
| 2022 | 14.82% | 19.38% | 0.60x | 1.28x | €50.59 Billion |
| 2023 | 14.05% | 19.73% | 0.59x | 1.20x | €45.77 Billion |
| 2024 | 18.40% | 27.90% | 0.53x | 1.23x | €109.20 Billion |
Industry Comparison
This section compares Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) | €1.30 Trillion | 7.80% | 0.23x | $4.70 Billion |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |